Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction

Add time:07/11/2019    Source:sciencedirect.com

The synthesis and biological evaluation of a series of novel 3-phenylpiperidine-4-carboxamide derivatives are described. These compounds are generated by hybridization of the substructures from two types of tachykinin NK1 receptor antagonists. Compound 42 showed high metabolic stability and excellent efficacy in the guinea-pig GR-73637-induced locomotive activity assay at 1 and 24 h after oral administration. It also exhibited good pharmacokinetic profiles in four animal species, and a low potential in a pregnane X receptor induction assay.

We also recommend Trading Suppliers and Manufacturers of (3-((1-(tert-butoxycarbonyl)piperidin-4-yl)carbaMoyl)phenyl)boronic acid (cas 1704074-10-1). Pls Click Website Link as below: cas 1704074-10-1 suppliers

Prev:Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y1 receptor antagonists
Next:A Waldenström macroglobulin which binds 3-Amino-2,4,6-triiodobenzoic acid (cas 3119-15-1)—II)